Page last updated: 2024-10-26

edrophonium and Clerambault Syndrome

edrophonium has been researched along with Clerambault Syndrome in 1 studies

Edrophonium: A rapid-onset, short-acting cholinesterase inhibitor used in cardiac arrhythmias and in the diagnosis of myasthenia gravis. It has also been used as an antidote to curare principles.
edrophonium : A quaternary ammonium ion that is N-ethyl-N,N-dimethylanilinium in which one of the meta positions is substituted by a hydroxy group. It is a reversible inhibitor of cholinesterase, with a rapid onset (30-60 seconds after injection) but a short duration of action (5-15 minutes). The chloride salt is used in myasthenia gravis both diagnostically and to distinguish between under- or over-treatment with other anticholinesterases. It has also been used for the reversal of neuromuscular blockade in anaesthesia, and for the management of poisoning due to tetrodotoxin, a neuromuscular blocking toxin found in puffer fish and other marine animals.

Research Excerpts

ExcerptRelevanceReference
"Physostigmine has been demonstrated to improve the abnormal movements in patients with tardive dyskinesia while scopolamine tends to aggravate abnormal movements and in some cases elicits abnormal movement not previously observed."1.25Effect of cholinergic and anticholinergic agents on tardive dyskinesia. ( Klawans, HL; Rubovits, R, 1974)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Klawans, HL1
Rubovits, R1

Other Studies

1 other study available for edrophonium and Clerambault Syndrome

ArticleYear
Effect of cholinergic and anticholinergic agents on tardive dyskinesia.
    Journal of neurology, neurosurgery, and psychiatry, 1974, Volume: 37, Issue:8

    Topics: Adult; Aged; Anxiety Disorders; Edrophonium; Female; Humans; Male; Middle Aged; Movement Disorders;

1974